567 news items
Market Whales and Their Recent Bets on PFE Options
PFE
22 May 24
prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular
Matica Bio at BIO International 2024: Leading the Way in CGT Innovation and U.S. Manufacturing Strategy
22 May 24
and collaboration opportunities. CHA Biotech will promote its NK cell-based cancer immunotherapy ‘CBT101' and explore CAR technology, while CHA Vaccine
VBI Vaccines To Present New Interim Phase 2b Data From VBI-1901 In Recurrent Glioblastoma Patients In Poster Presentation At 2024 ASCO Annual Meeting
VBIV
22 May 24
randomized, controlled Phase 2b study of VBI-1901, the Company's cancer vaccine immunotherapeutic candidate in recurrent glioblastoma (GBM), were
VBI Vaccines Announces Poster Presentation at 2024 ASCO Annual Meeting Highlighting New Interim Phase 2b Data from VBI-1901 in Recurrent Glioblastoma Patients
VBIV
22 May 24
tumor response data from the ongoing randomized, controlled Phase 2b study of VBI-1901, the Company's cancer vaccine immunotherapeutic candidate
Moderna Announces Data to be Presented at 2024 ASCO Annual Meeting
MRNA
22 May 24
neoantigen therapy (INT) V940 (mRNA-4157) plus pembrolizumab vs placebo plus pembrolizumab for resected early-stage non-small-cell lung cancer (NSCLC
be4j7 zptqcihy2hre8y88el3h2ip03
ACHL
ARCT
22 May 24
), an mRNA medicines company, to evaluate best-in-class, self-amplifying mRNA (sa-mRNA) personalized cancer vaccines (PCVs) targeting clonal neoantigens
javip18ztl47mq 36rt2w
22 May 24
for cervical cancer and sexually transmitted infections (STIs), breast exams, vaccination, laboratory testing, ultrasounds, contraceptive counseling
k3e4g2lnlw9s3uz4b79de0pr291ojtsabujfcpbydr4i7af
22 May 24
like cancer, kidney disease, and Crohn's disease, along with a rise in hospital-acquired infections and an aging population. Additionally
o7m047dq0n2yz687k
22 May 24
. Historical data for 2020 and 2021 and forecasts for 2022 to 2028 are provided. It should be noted that pEGylated vaccines are not included in the scope
887vg76vnfh6qyfofojwfsq6k7sm6acvte
ABUS
22 May 24
by the hepatitis B virus (HBV). HBV can cause chronic infection which leads to a higher risk of death from cirrhosis and liver cancer. Chronic HBV infection
w6yyjhm4qrocanr7qh
22 May 24
): this cancer vaccine is the Company's most advanced product; positive results from the Phase 3 trial (Atalante 1) in Non-Small Cell Lung Cancer patients
7jg1yrlc698znv qz7d0qp
YS
21 May 24
, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer, today announced the results
j4vrtklglcgykoe3zpgo1jbacfdfdwwo0wshir00grerbn17qesd yqk65y
21 May 24
/ -- Cancer Biomarkers
zu5zpcvyuz34oxtut2wee0rfsvkzfc
SNGX
21 May 24
-stage biopharmaceutical company is advancing a broad pipeline of therapeutic and vaccine candidates across its two business
e5ao2w3 hxqj
MRK
21 May 24
areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor
1cxx0pdy 7qdt
XSNX
21 May 24
cancer cells. The Company plans to use this patent to predict a patient's likely response to vaccine/immunotherapy during treatment for highly
xjthumiz9tyyjddyn9u36o3 pmzzwawyx9hox
LLY
21 May 24
.
Immunizations
Avoid use of live vaccines in patients treated
llckw 1qgb41
SNGX
21 May 24
), will be presenting key data from the Company's thermostable vaccine technology platform developed in collaboration with UHM, including results from the filovirus
jc2dw05m4ak7
ANIX
21 May 24
cancer, as well as additional cancer vaccines to address many intractable cancers, including high incidence malignancies in lung, colon, and prostate
v2d9ur8mux27mnhjg55s0ksh3ej1 2elnrjm1xc
BNTX
21 May 24
-based therapeutic cancer vaccines." Highlights of BioNTech's updates to be presented at the ASCO Annual Meeting 2024